Drug firm Eris Lifesciences today reported a 10.06 per cent rise in its consolidated net profit to Rs 74.92 crore for the quarter ended December 2017.
The company had posted a net profit of Rs 68.07 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.
Consolidated total income of the company also rose to Rs 214.75 crore for the quarter under consideration as against Rs 190 crore in the same period a year ago.
Shares of Eris Lifesciences closed 0.35 per cent higher at Rs 765.05 per scrip on BSE today.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)